Association between megakaryocyte abnormalities on bone marrow smear and response to thrombopoietin receptor agonists in adult patients with primary immune thrombocytopenia

References

• Cooper N, Bussel J The pathogenesis of immune thrombocytopaenic purpura. Br J Haematol 2006;133:364–374. 10.1111/j.1365-2141.2006.06024.x
   PubMed Web of Science ®Google Scholar
• Cines DB, Bussel JB, Liebman HA The ITP syndrome: pathogenic and clinical diversity. Blood 2009;113:6511–6521. 10.1182/blood-2009-01-129155
   PubMed Web of Science ®Google Scholar
• Audia S, Mahévas M, Nivet M, Ouandji S, Ciudad M, Bonnotte B Immune thrombocytopenia: recent advances in pathogenesis and treatments. HemaSphere 2021;5:574. 10.1097/HS9.0000000000000574
   Web of Science ®Google Scholar
• Zufferey A, Kapur R, Semple J Pathogenesis and therapeutic mechanisms in immune thrombocytopenia (ITP). Journal of Clinical Medicine 2017;6:16. 10.3390/jcm6020016
   PubMed Web of Science ®Google Scholar
• Kuter DJ The treatment of immune thrombocytopenia (ITP)—focus on thrombopoietin receptor agonists Ann Blood 2021 6 7 10.21037/aob-21-23
   Google Scholar
• Shrestha S, Nazy I, Smith JW, Kelton JG, Arnold DM Platelet autoantibodies in the bone marrow of patients with immune thrombocytopenia. Blood Adv 2020;4:2962–2966. 10.1182/bloodadvances.2020001846
   PubMed Web of Science ®Google Scholar
• Provan D, Arnold DM, Bussel JB , et al. Updated international consensus report on the investigation and management of primary immune thrombocytopenia. Blood Adv 2019;3:3780–3817. 10.1182/bloodadvances.2019000812
   PubMed Web of Science ®Google Scholar
• Neunert C, Terrell DR, Cooper N, et al. American society of hematology 2019 guidelines for immune thrombocytopenia. Blood Adv. 2019;3:38. 10.1182/bloodadvances.2019000966
   PubMed Web of Science ®Google Scholar
• Godeau, Bertrand, Aladjidi, Nathalie Protocole national de diagnostic et de soins (PNDS) : purpura thrombopenique immunologique de l’enfant et de l’adulte. Haute Autorité de Santé 2017
   Google Scholar
• Kuter DJ, Bussel JB , Senecal FM, et al. Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial. Lancet. 2008;371:9. 10.1016/S0140-6736(08)60046-X
   PubMed Web of Science ®Google Scholar
• Bussel JB, Provan D , Kovaleva L, et al. Effect of eltrombopag on platelet counts and bleeding during treatment of chronic idiopathic thrombocytopenic purpura: a randomised, double-blind, placebo-controlled trial. Lancet. 2009;373:8.
   Web of Science ®Google Scholar
• Ghanima W, Godeau B, Cines DB, Bussel JB How I treat immune thrombocytopenia: the choice between splenectomy or a medical therapy as a second-line treatment. Blood 2012;120:960–969. 10.1182/blood-2011-12-309153
   PubMed Web of Science ®Google Scholar
• Ghanima W, Cooper N, Rodeghiero F, Godeau B, Bussel JB Thrombopoietin receptor agonists: ten years later. Haematologica 2019;104:1112–1123. 10.3324/haematol.2018.212845
   PubMed Web of Science ®Google Scholar
• Wong RSM, Saleh MN, Burgess P, et al. Safety and efficacy of long-term treatment of chronic/persistent ITP with eltrombopag: final results of the EXTEND study. Blood 2017;130:2527–2536. 10.1182/blood-2017-04-748707
   PubMed Web of Science ®Google Scholar
• Kapur R, Aslam R, Speck ER, Rebetz JM, Semple JW Thrombopoietin receptor agonist (TPO-RA) treatment raises platelet counts and reduces anti-platelet antibody levels in mice with immune thrombocytopenia (ITP). Platelets 2020;31:399–402. 10.1080/09537104.2019.1624709
   PubMed Web of Science ®Google Scholar
• Al-Samkari H, Kuter DJ Thrombopoietin level predicts response to treatment with eltrombopag and romiplostim in immune thrombocytopenia. Am J Hematol 2018;93:1501–1508. 10.1002/ajh.25275
   PubMed Web of Science ®Google Scholar
• Houwerzijl EJ, Blom NR , Smit JW, et al. Ultrastructural study shows morphologic features of apoptosis and para-apoptosis in megakaryocytes from patients with idiopathic thrombocytopenic purpura. Blood 2004;103:500–506. 10.1182/blood-2003-01-0275
   PubMed Web of Science ®Google Scholar
• Hogan M, Geyer JT, Bussel JB Response to thrombopoietic agents is related to on‐treatment bone marrow megakaryocyte morphology in patients with chronic immune thrombocytopenia. Am J Hematol 2019;25496. 10.1002/ajh.25496
   Web of Science ®Google Scholar
• Muhury M, Mathai AM, Sharada R, Ramadas N, Muktha RP, Ruchi S Megakaryocytic alterations in thrombocytopenia: a bone marrow aspiration study. J Pathol Microbiol 2009;52:490–494.
   Google Scholar
• Deka L, Gupta S, Gupta R, Pant L, Kaur CJ, Singh S Morphometric evaluation of megakaryocytes in bone marrow aspirates of immune-mediated thrombocytopenic purpura. Platelets 2013;24:113–117. 10.3109/09537104.2012.667852
   PubMed Web of Science ®Google Scholar
• Tripathi AK, Mishra S, Kumar A, Yadav D, Shukla A, Yadav Y Megakaryocyte morphology and its impact in predicting response to steroid in immune thrombocytopenia. Platelets 2014;25:526–531. 10.3109/09537104.2013.845875
   PubMed Web of Science ®Google Scholar
• Zhu J, Chen R, Xie M, et al. A megakaryocyte morphological classification-based predictive model for steroid sensitivity in primary immune thrombocytopenia. Platelets 2019;30:1–6.10.1080/09537104.2019.1549810
   PubMedGoogle Scholar
• Moulis G, Sailler L, Adoue D, Lapeyre-Mestre M Pharmacoepidemiology of immune thrombocytopenia: protocols of FAITH and CARMEN studies. Therapies 2014;69:437–448. 10.2515/therapie/2014056
   PubMed Web of Science ®Google Scholar
• Rodeghiero F, Stasi R, Arnold DM, et al. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood 2009;113:2386–2393. 10.1182/blood-2008-07-162503
   PubMed Web of Science ®Google Scholar
• Moulis G, Germain J, Castel B, et al. Newly diagnosed immune thrombocytopenia adults: clinical epidemiology, exposure to treatments, and evolution. results of the CARMEN multicenter prospective cohort. Am J Hematol 2017;92:493–500. 10.1002/ajh.24702
   PubMed Web of Science ®Google Scholar
• Moulis G, Palmaro A, Montastruc J-L, Godeau B, Lapeyre-Mestre M, Sailler L Epidemiology of incident immune thrombocytopenia: a nationwide population-based study in France. Blood 2014;124:3308–3315. 10.1182/blood-2014-05-578336
   PubMed Web of Science ®Google Scholar